AbCellera Biologics Inc. (ABCL): Shares Outstanding

Annual figures by period end, from SEC filings.

300.60M
As of 2025-12-31
306.47M
As of 2026-06-30
+1.6%
3-year compound annual growth
+2.2%
5-year compound annual growth
2020-12-31: 269.50M2021-12-31: 283.26M2022-12-31: 286.85M2023-12-31: 290.82M2024-12-31: 295.76M2025-12-31: 300.60M300.60M
2020-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-31300.60M+1.6%2026-02-24, Balance as of period end
2024-12-31295.76M+1.7%2026-02-24, Balance as of period end
2023-12-31290.82M+1.4%2025-02-27, Balance as of period end
2022-12-31286.85M+1.3%2024-02-20, Balance as of period end
2021-12-31283.26M+5.1%2023-02-21, Balance as of period end
2020-12-31269.50Mn/a2022-02-25, Balance as of period end